新生儿换血输血后的疫苗免疫应答、自身免疫与患病率
该单中心回顾性病例对照队列研究纳入74名足月适龄健康儿童,41名因新生儿溶血病接受换血输血(BET)且后续未用其他血制品,33名未接受任何血制品,均接种四剂白喉破伤风类毒素疫苗。结果发现BET组白喉抗体应答明显增强(1.016 IU/mL,95%CI 0.662-1.369 vs 0.515 IU/mL,95%CI 0.363-0.626,P=0.011),破伤风应答略增强,自身免疫倾向有升高趋势(25.8% vs 12.5%,P非特异性),但除水痘外未影响感染、自身免疫及肿瘤疾病发生。
要点
- 新生儿换血输血可增强白喉疫苗的体液免疫应答(P=0.011)。
- BET组自身抗体有升高趋势,但未显著增加自身免疫病发生。
- 除水痘外,BET未影响细菌、儿童病毒感染及肿瘤患病率。
核心结论
- 新生儿期换血输血影响白喉和破伤风疫苗的体液免疫应答及自身抗体产生,但未影响患病率和自身免疫病发生。
研究设计与样本
- 单中心回顾性病例对照队列研究,纳入74名足月适龄健康儿童,41名接受换血输血,33名未接受血制品,均接种四剂白喉破伤风类毒素疫苗。
主要发现
- BET组白喉抗体为1.016 IU/mL(95%CI 0.662-1.369),对照组为0.515 IU/mL(95%CI 0.363-0.626),P=0.011。
- BET组破伤风抗体为1.798 IU/mL(95%CI 1.180-2.416),对照组为1.036 IU/mL(95%CI 0.398-1.673),P为非特异性。
- BET组自身免疫倾向为25.8%,对照组为12.5%,P为非特异性。
- 水痘发生率为43.9% vs 21.2%,P=0.040,其余感染、自身免疫及肿瘤疾病无差异。
临床怎么用
- 对新生儿期接受换血输血的儿童,可关注其白喉、破伤风疫苗免疫应答及自身抗体情况。
- 换血输血后除水痘外未增加其他疾病风险,无需因此改变常规预防保健。
局限性
- 单中心回顾性设计,样本量较小,部分比较P值为非特异性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: A blood exchange transfusion (BET) is most commonly performed to treat severe neonatal haemolytic disease. A distinct form of blood transfusion adverse reaction is transfusion-related immunomodulation. The purpose of our retrospective single-centre case-control cohort study was to investigate whether a blood exchange transfusion in the neonatal period provokes immunomodulation and affects humoral immune response to vaccination, morbidity and occurrence of autoantibodies. METHODS: Study subjects were 74 apparently healthy children, who were born at term as appropriate for gestational age and received four doses of diphtheria and tetanus toxoid vaccine. Forty-one received BET due to neonatal hemolytic disease and no other blood product afterwards, while 33 did not receive any blood products. Analysis of diphtheria, tetanus and autoimmune antibodies was performed and their medical records were analyzed for infectious, allergic, cancerous and autoimmune diseases. RESULTS: A clearly exaggerated immune response to diphtheria (1.016 IU/mL, 95% confidence interval (CI) 0.662-1.369 IU/mL vs. 0.515 IU/mL, 95% CI 0.363 to 0.626 IU/mL, P = 0.011) and slightly exaggerated immune response to tetanus vaccine (1.798 IU/mL, 95% CI 1.180-2.416 IU/mL vs. 1.036 IU/mL, 95% CI 0.398-1.673 IU/mL, P = non-specific) were observed in BET subjects. A propensity towards autoimmunity (25.8% vs. 12.5%, P = non-specific) was observed in BET subjects. However, BET in the neonatal period did not influence the occurrence of bacterial, childhood viral diseases with exception of varicella (43.9% vs. 21.2%, P = 0.040), autoimmune and cancer diseases. CONCLUSION: BET impacted humoral immune response to diphtheria and tetanus vaccine and occurrence of autoimmune antibodies, but did not affect morbidity and the occurrence of autoimmune diseases. These effects could be related to massive antigenic load of BET and an accelerated priming of immune cells and consequent immunomodulation.
引用
- Nosan G, Paro-Panjan D, Ihan A, et al. Vaccine immune response, autoimmunity and morbidity after neonatal blood exchange transfusion. Vaccine. 2019. PMID: 31160098. doi:10.1016/j.vaccine.2019.05.077
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。